---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-051097"
form_type: "8-K"
ticker: "NKTR"
cik: "0000906709"
company_name: "NEKTAR THERAPEUTICS"
filed_at: "2023-06-23T23:59:59+00:00"
generated_at: "2026-06-13T18:43:01.864327+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Nektar Therapeutics CFO separation agreement provides $880K severance

## Summary
- CFO Jillian Thomsen's employment terminated June 16, 2023; transition period from April 17.
- Company to pay $880,000 lump sum severance, plus COBRA through June 30, 2024.
- Career transition services and IT equipment benefits included in agreement.
- Agreement contains standard release of claims and negative PTO balance waiver.

## SEC filing metadata
- accession: 0001213900-23-051097
- form_type: 8-K
- ticker: NKTR
- cik: 0000906709
- company_name: NEKTAR THERAPEUTICS
- filed_at: 2023-06-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/906709/000121390023051097/0001213900-23-051097-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/906709/000121390023051097/ea180833-8k_nektar.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-051097
- JSON: https://secwatch.observer/filing/0001213900-23-051097.json
- Plain text: https://secwatch.observer/filing/0001213900-23-051097.txt

## Key facts
- Executive change
  Jillian Thomsen departed as Chief Financial Officer at NEKTAR THERAPEUTICS.
  - Action: stepped down
  - Role: Chief Financial Officer
  source text: On April 17, 2023, Nektar Therapeutics (the “Company”) announced that Jillian Thomsen will step down as the Chief Financial Officer of the Company effective as of April 17, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/906709/000121390023051097/0001213900-23-051097-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.